In January 1400, the market value of Barakat Pharmaceutical Group increased by about 1,807 billion tomans to about 4,090 billion tomans. The increase of 1,807 billion Tomans in the value of Alborz Holding (from
In January 1400, the market value of Barakat Pharmaceutical Group increased by about 1,807 billion tomans to about 4,090 billion tomans. The increase of 1,807 billion Tomans in the value of Alborz Holding (from the group of pharmaceutical materials and products) had the greatest impact on this growth. On the other hand, drug production with a drop of 64 million Tomans had the most negative impact on the company’s portfolio.
